Search Results 801-810 of 19280 for Myocardium

1. Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study - Mayo Clinic

   Subjects with severe cardiopulmonary disease or other serious organic disease which might include known history of coronary artery disease, myocardial ...

2. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   Significant cardiovascular disease (e.g., myocardial infarction, arterial thromboembolism, cerebrovascular thromboembolism) within 6 months prior to start ...

3. Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy with Adjuvant PCV Chemotherapy in Patients with Anaplastic Glioma or Low Grade Glioma - Mayo Clinic

   - History of myocardial infarction =< 6 months, or congestive heart failure requiring use of ongoing maintenance therapy for life-threatening ventricular ...

4. Publications - Tim Leiner, M.D., Ph.D. - Mayo Clinic

   ... myocardial scar and microvascular obstruction on late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2026 Mar 12; 102712 ...

5. Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial Of QPI-1007 In Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) - Mayo Clinic

   History of myocardial infarction within the last 6 months. Participating in a concurrent interventional study with the last intervention occurring within 30 ...

6. A Study to Evaluate the Safety, Effectiveness and Tolerability of APG-2575 in Patients with Waldenström Macroglobulinemia - Mayo Clinic

   Association Functional Classification; or a history of myocardial infarction, unstable angina, or acute coronary syndrome within 6 months prior to randomization ...

7. A Clinical Trial To Assess The Safety Of A Novel Scaffold Biomaterial

   Have any major, clinically significant medical condition (e.g., within six months of baseline, had myocardial infarction, angina pectoris, and/or congestive ...

8. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

   Participation eligibility · Prior solid organ transplantation. · Unstable angina, clinically significant arrhythmia, or myocardial infarction ≤ 6 months of prior ...

9. A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer - Mayo Clinic

   Myocardial infarction within 12 months of study day 1, symptomatic congestive heart failure (New York Heart Association > class II), unstable angina, or ...

10. Cardiovascular Medicine - Clinical trials

    The purpose of this study is to establish a registry that will address the data gap regarding the course of NSTEMI (Non-ST-Elevation Myocardial Infarction) ...